Kangstem Biotech Co., Ltd. (KOSDAQ: 217730)
South Korea
· Delayed Price · Currency is KRW
1,408.00
-2.00 (-0.14%)
Sep 11, 2024, 3:13 PM KST
Kangstem Biotech Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 10, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 78,812 | 133,971 | 109,830 | 124,057 | 196,458 | 169,714 | |
Market Cap Growth | 25.43% | 21.98% | -11.47% | -36.85% | 15.76% | -62.62% | |
Enterprise Value | 56,219 | 129,761 | 85,183 | 115,828 | 180,137 | 145,899 | |
Last Close Price | 1406.00 | 2395.00 | 2514.77 | 2840.52 | 5613.97 | 5777.21 | |
PE Ratio | - | -4.43 | -4.71 | -3.71 | -6.78 | -4.89 | |
PS Ratio | 5.25 | 10.55 | 6.74 | 10.00 | 21.50 | 28.26 | |
PB Ratio | 1.53 | 2.67 | 2.08 | 1.74 | 4.04 | 2.47 | |
P/FCF Ratio | -9.14 | -7.49 | -5.61 | -5.74 | -11.53 | -5.92 | |
P/OCF Ratio | -9.98 | -8.12 | -5.82 | -7.30 | -14.04 | -12.74 | |
EV/Sales Ratio | 4.23 | 10.21 | 5.23 | 9.34 | 19.71 | 24.30 | |
EV/EBITDA Ratio | -8.32 | -6.88 | -5.10 | -6.14 | -11.45 | -6.93 | |
EV/EBIT Ratio | -6.82 | -5.70 | -4.14 | -5.09 | -9.62 | -6.30 | |
EV/FCF Ratio | -3.26 | -7.25 | -4.35 | -5.36 | -10.58 | -5.09 | |
Debt / Equity Ratio | 0.15 | 0.27 | 0.25 | 0.20 | 0.37 | 0.45 | |
Debt / FCF Ratio | -0.44 | -0.76 | -0.68 | -0.65 | -1.07 | -1.08 | |
Asset Turnover | 0.19 | 0.16 | 0.18 | 0.13 | 0.09 | 0.06 | |
Inventory Turnover | 13.27 | 21.16 | 18.57 | 17.37 | 26.05 | 5.88 | |
Quick Ratio | 2.44 | 2.07 | 2.73 | 3.38 | 3.18 | 2.36 | |
Current Ratio | 3.09 | 2.55 | 3.22 | 3.80 | 3.67 | 2.69 | |
Return on Equity (ROE) | -25.70% | -45.17% | -32.55% | -36.40% | -33.65% | -45.39% | |
Return on Assets (ROA) | -18.75% | -17.59% | -13.99% | -15.31% | -11.93% | -15.49% | |
Return on Capital (ROIC) | -23.01% | -21.93% | -16.97% | -18.68% | -14.06% | -17.58% | |
Earnings Yield | -14.00% | -16.38% | -18.42% | -17.21% | -9.40% | -14.52% | |
FCF Yield | -21.86% | -13.35% | -17.82% | -17.43% | -8.67% | -16.89% | |
Buyback Yield / Dilution | -31.71% | -7.02% | -36.23% | -24.89% | -6.99% | -13.71% | |
Total Shareholder Return | -31.71% | -7.02% | -36.23% | -24.89% | -6.99% | -13.71% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.